Hui Zheng | Bioengneering | Best Researcher Award Published on 22/09/202522/09/2025 by CAD Awards Dr. Hui Zheng | Bioengneering | Best Researcher Award Program Leader | Hunan University | China Dr. Zheng Hui is a researcher specializing in biomedical materials with a strong background in clinical medicine and orthopedics, holding a Ph.D. in Biomedical Materials from Hunan University, an M.S. in Orthopedics from Southern Medical University, and a B.S. in Clinical Medicine from Jiujiang University. He has combined medical training with advanced research in biomaterials and tissue engineering, with expertise in bone and cartilage tissue engineering, piezoelectric biomaterials, the molecular mechanisms of osteoarthritis, and the clinical translation of biomedical materials. His innovative work has been published in high-impact journals such as Acta Biomaterialia, Materials Today Bio, and the Journal of Orthopaedic Translation, earning recognition and awards for his contributions to bone and cartilage regeneration and biomaterials research. With 20 citations across 20 documents, 2 indexed publications, and an h-index of 2, he demonstrates growing international impact, and his multidisciplinary expertise bridging clinical medicine and advanced biomaterials positions him as a promising scientist with strong potential to advance regenerative medicine through novel biomaterials, piezoelectric scaffolds, immunomodulation, and translational strategies. Profile: Scopus Featured Publications Zheng, H., Fang, J., Hu, S., Xie, D., Fang, H., & Zhang, R. (2024). TCF12 regulates the TGF-β/Smad2/3 signaling pathway to accelerate the progression of osteoarthritis by targeting CXCR4. Journal of Orthopaedic Translation, 44, 35–46.
Dr. Zheng Hui is a researcher specializing in biomedical materials with a strong background in clinical medicine and orthopedics, holding a Ph.D. in Biomedical Materials from Hunan University, an M.S. in Orthopedics from Southern Medical University, and a B.S. in Clinical Medicine from Jiujiang University. He has combined medical training with advanced research in biomaterials and tissue engineering, with expertise in bone and cartilage tissue engineering, piezoelectric biomaterials, the molecular mechanisms of osteoarthritis, and the clinical translation of biomedical materials. His innovative work has been published in high-impact journals such as Acta Biomaterialia, Materials Today Bio, and the Journal of Orthopaedic Translation, earning recognition and awards for his contributions to bone and cartilage regeneration and biomaterials research. With 20 citations across 20 documents, 2 indexed publications, and an h-index of 2, he demonstrates growing international impact, and his multidisciplinary expertise bridging clinical medicine and advanced biomaterials positions him as a promising scientist with strong potential to advance regenerative medicine through novel biomaterials, piezoelectric scaffolds, immunomodulation, and translational strategies. Profile: Scopus Featured Publications Zheng, H., Fang, J., Hu, S., Xie, D., Fang, H., & Zhang, R. (2024). TCF12 regulates the TGF-β/Smad2/3 signaling pathway to accelerate the progression of osteoarthritis by targeting CXCR4. Journal of Orthopaedic Translation, 44, 35–46.